Zai Lab (ZLAB) Other financing activities (2019 - 2026)
Zai Lab (ZLAB) posted Other financing activities of $833000.0 for Q1 2026, up 234.54% sequentially from $249000.0 in Q4 2025, and down 72.32% YoY from $3.0 million in Q1 2025.
Zai Lab (ZLAB) Other financing activities (2019 - 2026) Analysis & Trends
Zai Lab has reported Other financing activities for 8 years, with the latest figure at $833000.0 in Q1 2026.
- Quarterly Other financing activities fell 72.32% year-over-year to $833000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 85.2% YoY) and the FY2025 annual result came in at $13.7 million, up 327.34% from the prior year.
- Other financing activities rose to $833000.0 in Q1 2026 per ZLAB's latest filing, from $249000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $8.4 million in Q2 2025 and troughed at $44000.0 in Q2 2024.
- A 5-year average of $1.6 million and a median of $927000.0 in 2022 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 22900.0% in 2022, down 99.47% in 2022.
- Over 5 years, Other financing activities stood at $230000.0 in 2022, then jumped by 104.35% to $470000.0 in 2023, then soared by 299.79% to $1.9 million in 2024, then tumbled by 86.75% to $249000.0 in 2025, then surged by 234.54% to $833000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $833000.0, $249000.0, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 946,000.00 |
| Jun 30, 2026 | 946,000.00 |
| Mar 31, 2026 | 833,000.00 |
| Mar 31, 2026 | 833,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 1.98 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Dec 31, 2023 | 470,000.00 |
| Dec 31, 2023 | 470,000.00 |